MSB 2.10% $1.17 mesoblast limited

Ann: Remestemcel-L for COVID-19 MIS-C published in Pediatrics, page-60

  1. 11,423 Posts.
    lightbulb Created with Sketch. 504
    Bodes well for Novartis paying on time to me thinks.

    The NIH the Government Department that run the Covid ARDS Trial whom are committed to understanding the science as their Mission Statement states will probably look at it to me thinks further.

    Doctors encouraged to write article by mesoblast and present before ARDS Trial readout or Doctors bless their souls seeking to promote for ill childrens sake?
    Last edited by eyeswideopen: 17/02/21
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.17
Change
-0.025(2.10%)
Mkt cap ! $1.330B
Open High Low Value Volume
$1.18 $1.22 $1.15 $6.344M 5.404M

Buyers (Bids)

No. Vol. Price($)
1 8683 $1.16
 

Sellers (Offers)

Price($) Vol. No.
$1.17 32999 1
View Market Depth
Last trade - 16.10pm 15/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.